XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Balance at the beginning at Dec. 31, 2021 $ 344,747 $ 88 $ 506,760 $ (765) $ (161,336)
Balance at the beginning (in Shares) at Dec. 31, 2021   87,598,184      
Issuance of common stock from exercise of options and employee stock purchase plan 265   265    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   111,315      
Stock based compensation expense 3,205   3,205    
Business combination and PIPE financing, issuance costs (8)   (8)    
Other comprehensive income (loss) (2,645)     (2,645)  
Net loss (25,208)       (25,208)
Balance at the ending at Mar. 31, 2022 320,356 $ 88 510,222 (3,410) (186,544)
Balance at the ending (in Shares) at Mar. 31, 2022   87,709,499      
Balance at the beginning at Dec. 31, 2021 344,747 $ 88 506,760 (765) (161,336)
Balance at the beginning (in Shares) at Dec. 31, 2021   87,598,184      
Net loss (79,116)        
Balance at the ending at Sep. 30, 2022 273,072 $ 88 518,292 (4,856) (240,452)
Balance at the ending (in Shares) at Sep. 30, 2022   88,067,254      
Balance at the beginning at Mar. 31, 2022 320,356 $ 88 510,222 (3,410) (186,544)
Balance at the beginning (in Shares) at Mar. 31, 2022   87,709,499      
Issuance of common stock from exercise of options and employee stock purchase plan 718   718    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   288,450      
Stock based compensation expense 3,425   3,425    
Other comprehensive income (loss) (937)     (937)  
Net loss (24,858)       (24,858)
Balance at the ending at Jun. 30, 2022 298,704 $ 88 514,365 (4,347) (211,402)
Balance at the ending (in Shares) at Jun. 30, 2022   87,997,949      
Issuance of common stock from exercise of options and employee stock purchase plan 112   112    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   69,305      
Stock based compensation expense 3,815   3,815    
Other comprehensive income (loss) (509)     (509)  
Net loss (29,050)       (29,050)
Balance at the ending at Sep. 30, 2022 273,072 $ 88 518,292 (4,856) (240,452)
Balance at the ending (in Shares) at Sep. 30, 2022   88,067,254      
Balance at the beginning at Dec. 31, 2022 249,476 $ 88 522,605 (3,705) (269,512)
Balance at the beginning (in Shares) at Dec. 31, 2022   88,179,374      
Issuance of common stock from exercise of options and employee stock purchase plan 73   73    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   30,590      
Stock based compensation expense 4,219   4,219    
Other comprehensive income (loss) 1,504     1,504  
Net loss (28,008)       (28,008)
Balance at the ending at Mar. 31, 2023 227,264 $ 88 526,897 (2,201) (297,520)
Balance at the ending (in Shares) at Mar. 31, 2023   88,209,964      
Balance at the beginning at Dec. 31, 2022 249,476 $ 88 522,605 (3,705) (269,512)
Balance at the beginning (in Shares) at Dec. 31, 2022   88,179,374      
Net loss (70,981)        
Balance at the ending at Sep. 30, 2023 276,595 $ 102 617,667 (681) (340,493)
Balance at the ending (in Shares) at Sep. 30, 2023   101,847,154      
Balance at the beginning at Mar. 31, 2023 227,264 $ 88 526,897 (2,201) (297,520)
Balance at the beginning (in Shares) at Mar. 31, 2023   88,209,964      
Issuance of common stock from exercise of options and employee stock purchase plan 586   586    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   252,880      
Stock based compensation expense 5,121   5,121    
Other comprehensive income (loss) 684     684  
Net loss (20,710)       (20,710)
Balance at the ending at Jun. 30, 2023 212,945 $ 88 532,604 (1,517) (318,230)
Balance at the ending (in Shares) at Jun. 30, 2023   88,462,844      
Issuance of common stock from exercise of options and employee stock purchase plan 441   441    
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)   187,639      
Issuance of common stock and pre-funded warrants, net (in Shares)   13,196,671      
Issuance of common stock and pre-funded warrants, net 79,776 $ 14 79,762    
Stock based compensation expense 4,860   4,860    
Other comprehensive income (loss) 836     836  
Net loss (22,263)       (22,263)
Balance at the ending at Sep. 30, 2023 $ 276,595 $ 102 $ 617,667 $ (681) $ (340,493)
Balance at the ending (in Shares) at Sep. 30, 2023   101,847,154